4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-028714
SVP, Head of Global Commercial sold 1,544 shares at $40.15 ($61,992)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Porter Derrell SVP, Head of Global Commercial | 2018-05-08 | Sale | −1,544 | $40.15 | $61,992 | 12,500 | D: show line 1 in the form |
| Open-market sales · 1,544 sh · avg $40.15 · $61,992 | |||||||
Loading xslF345X03/doc4.xml…